Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 92%
filed 2026-06-24
Worksport entered into two registered direct offerings on June 17–18, 2026, issuing 208,333 shares at $1.20 per unit (with warrants) and 675,529 shares at $0.70 per share, totaling approximately $722,870 in gross proceeds. The offerings include dilutive equity issuances and warrant grants with cashless exercise features, characteristic of a registered direct offering (PIPE-like structure). This is a material capital raise that dilutes existing shareholders and is disclosed under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-06-24
EX-99.1
Autozi announced execution of a Securities Purchase Agreement under which it issued convertible promissory notes totaling $5.25 million in gross proceeds, with an additional $2.5 million option. The notes are convertible into Ordinary Shares at a conversion price based on closing sale price at time of conversion. This is a dilutive equity issuance offered under Section 4(a)(2) and Regulation D exemptions, materially affecting shareholder equity and ownership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
HPS Corporate Capital Solutions Fund completed an unregistered private placement of approximately $16.91 million in common shares of beneficial interest across Class I and Class D shares, issued to accredited investors and non-U.S. persons pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The filing discloses an unregistered sale of equity securities totaling approximately $243.9 million across three share classes (Class I, S, and D) on June 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement. The materiality is underscored by the substantial aggregate consideration and the disclosure that the company has raised approximately $7.3 billion cumulatively since inception through such continuous private offerings.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The Company completed an unregistered sale of approximately $281 million in equity securities across multiple share classes (Class I, U, D, and S shares) to investors on June 1, 2026, exempt under Section 4(a)(2) and Regulations D and S. This private placement is part of the Company's ongoing continuous offering structure and materially affects shareholder ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
The filing discloses an unregistered sale of 961,171 common shares for $25,125,000 pursuant to Section 4(a)(2) and Regulation D/S under the Securities Act. This is a classic dilutive equity issuance by a closed-end fund raising capital through a private placement, which is material to existing shareholders as it increases share count and dilutes ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
TPG Private Equity Opportunities, L.P. sold $99.2 million of unregistered limited partnership units on June 1, 2026, across multiple unit classes (Class I, S, and F) to third-party investors and through a feeder vehicle, pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-24
Item 3.02
Carlyle Private Equity Partners Fund sold approximately $16.4 million in unregistered limited partnership units on June 1, 2026, pursuant to a continuous private offering under Section 4(a)(2) and Regulation D, diluting existing unitholders' ownership interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-23
Item 8.01
The filing discloses settlement of forward sale agreements under an ATM equity distribution program and underwritten forward sale agreements, resulting in the delivery of approximately 8.7 million shares of common stock and generating ~$672 million in gross proceeds. These forward sale agreements represent dilutive equity issuances that were previously entered into and are now being physically settled. The magnitude of shares issued and cash raised, combined with the disclosure of substantial remaining outstanding forward obligations (~11.1 million shares worth ~$915 million), constitutes a material capital-raising event affecting shareholder equity and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 1.01
AMC entered into a securities purchase agreement on June 23, 2026 to sell 95,250,000 shares of Class A common stock at $2.10 per share in a registered direct offering, raising approximately $200 million in gross proceeds for debt redemption and general corporate purposes. This material registered equity issuance will dilute existing shareholders' voting power and ownership percentage.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The company issued 21,953,577 shares of Reorganized Common Equity and New Warrants (exercisable for 5.0% of outstanding equity) without registration under the Securities Act in reliance on Section 1145(a) of the Bankruptcy Code to debt holders and other claimants in connection with the bankruptcy emergence.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Eagle Point Trinity Senior Secured Lending Co issued 36,782.83 common shares for $373,000 in aggregate proceeds pursuant to subscription agreements, with the offer and sale exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
EX-99.2
Westport completed a registered direct offering of 1.6 million common shares and 3.25 million pre-funded warrants, combined with a concurrent private placement of 4.85 million warrants, raising approximately US$10 million in gross proceeds with potential for an additional US$10 million upon warrant exercise. The offering involved both registered and unregistered securities (private placement warrants under Section 4(a)(2) and Regulation D), materially diluting existing shareholders.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 65%
filed 2026-06-23
EX-99.1
The press release announces a 1-for-25 reverse stock split effective June 26, 2026, reducing outstanding shares from ~15.1 million to ~605,000. While a reverse split itself is not a new issuance, it is a capital structure event that signals potential delisting risk mitigation—the Company explicitly states the purpose is "to maintain compliance with Nasdaq's continued listing requirements," suggesting the stock price had fallen below minimum thresholds. This is material to investors as it reflects compliance pressure and dilution concerns, though the classification is somewhat ambiguous between `dilutive_issuance` (capital structure change affecting share value) and `delisting_risk` (the underlying compliance issue). The reverse split is the disclosed action, making `dilutive_issuance` the best fit, though confidence is moderate given the reverse split itself does not create new shares.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The Company entered into a Securities Purchase Agreement on June 23, 2026, to issue a convertible promissory note ($1.5M principal at initial closing, up to $2M total) and warrants to purchase 468,978 Class A ordinary shares. The convertible note and warrant structure creates significant dilution to existing shareholders through conversion and exercise rights. This is a classic PIPE-like transaction raising capital through unregistered securities with conversion/exercise features, fitting the dilutive_issuance taxonomy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Serapha Bio is raising $230 million through a private placement of capital stock in connection with the proposed merger, with approximately $138 million already funded in a Series A financing and $92 million expected to close concurrently with the merger closing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Stepstone Private Credit Fund LLC completed an unregistered sale of 10,650,045 LLC interests for $279.6 million pursuant to subscription agreements, relying on Section 4(a)(2), Regulation D, and Regulation S exemptions. This private placement materially affects the registrant's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Vista Credit Strategic Lending Corp. completed an unregistered sale of 147,178.274 shares of Class I and Class S common stock for $2,808,500 pursuant to subscription agreements, relying on Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
North Haven Private Income Fund LLC completed an unregistered sale of approximately 338,864 Class S units for $6.12 million, relying on Section 4(a)(2) and Regulation D exemptions with accredited investor representations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
North Haven Private Income Fund A LLC completed an unregistered private placement of approximately 24,412 Class I units for $0.5 million at $19.81 per unit, pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
LGAM Private Credit LLC sold approximately 263,964 Common Units for $5.2 million at $19.61 per unit pursuant to subscription agreements, relying on Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 1.01
Zoomcar entered into a securities purchase agreement for a private placement of Series A Convertible Preferred Stock, Warrants, and Placement Agent Warrants under Section 4(a)(2) and Regulation D Rule 506(c), with the Second Closing involving issuance of 662 Units for approximately $537,000 in gross proceeds. The Preferred Shares are convertible into Common Stock at $0.05 per share and Warrants are exercisable at $0.0625 per share, materially diluting existing shareholders' ownership.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-23
Item 3.02
Aditxt conducted an unregistered sale of equity securities (Additional Notes) to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b), representing a material private placement exempt offering.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
E-Power Inc. entered into a subscription agreement on June 16, 2026, to issue 15,841,585 Class A ordinary shares at $1.01 per share for an aggregate purchase price of $16,000,000.85 to a non-U.S. purchaser under Regulation S. This is a private placement of equity securities that will dilute existing shareholders and raise capital, fitting the definition of dilutive_issuance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-23
Item 3.02
The Company completed an unregistered private placement of a convertible note that would result in issuance of 20,000 private placement units upon conversion, together with warrants exercisable for Class A ordinary shares, relying on Section 4(a)(2) exemption for sophisticated investors.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The 6-K discloses a registered direct offering of 6,441,012 Class A ordinary shares at US$0.45645 per share for aggregate gross proceeds of approximately US$2.94 million. This is a direct equity issuance to investors pursuant to a Securities Purchase Agreement dated June 19, 2026, and is expected to close on or about June 25, 2026. The offering is registered under Form F-3 and represents a material capital-raising event that would dilute existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-23
The filing discloses conversion of Series B Convertible Preferred Stock into common stock following stockholder approval at a June 12, 2026 special meeting. The conversion resulted in 53,539,119 shares of common stock outstanding as of June 17, 2026, and required Nasdaq Listing Rule 5635(d) approval because the issuance exceeded 19.99% of previously outstanding shares. This is a material dilutive issuance of equity securities that materially increases share count and would affect investor assessment of ownership dilution and voting power.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-06-23
EX-99.1
This exhibit is a Securities Purchase Agreement for an unregistered private placement of up to $30,000,000 of Ordinary Shares at USD 0.6 per share to non-US persons under Regulation S and Section 4(a)(2) exemptions. The agreement explicitly states the Company is relying on exemptions from securities registration and the Purchasers are "non-US persons" acquiring securities in a private placement. This is a material dilutive issuance of equity securities outside a registered offering, typical of PIPE or private placement activity that would materially affect shareholder equity and voting power.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Dreamland Limited entered into a securities purchase agreement on June 22, 2026, to issue 320,000 Class A ordinary shares at US$3.75 per share for aggregate gross proceeds of US$1,200,000. The shares were issued in an unregistered offshore transaction under Regulation S to a non-U.S. person (Imperial Vision Fund SPC Series 1 SP), with transfer restrictions and restrictive legends. This is a classic private placement of unregistered equity securities, which is material to investors as it represents dilution and a capital raise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses an unregistered private placement of 201,500 restricted shares of common stock to five private investors at $2.75 per share, completed in March and April 2026 and closed on June 23, 2026. Items 1.01 and 3.02 explicitly describe the issuance and claim exemptions under Section 4(a)(2) and Regulation D, which are hallmarks of a dilutive equity issuance. This represents a material capital-raising event that would affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses entry into securities purchase agreements under Item 1.01 for the issuance of up to 43.3 billion units (each consisting of one share of common stock and one warrant) at $0.015 per unit for approximately $650 million in gross proceeds. An initial closing on June 22, 2026 resulted in issuance of 1.8 billion shares of common stock (900 million shares plus 900 million from warrant exercise). This is a classic dilutive private placement of equity securities to non-U.S. investors, materially diluting existing shareholders and raising substantial capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Sharplink entered into a securities purchase agreement on June 22, 2026, to sell 10,013,351 shares of common stock at $7.49 per share (approximately $75 million gross proceeds) plus 10,013,351 warrants with an exercise price of $8.15 per share. This is a registered direct offering disclosed under Item 1.01 (Entry into a Material Definitive Agreement), representing a dilutive equity issuance to raise capital for cryptocurrency acquisition and general corporate purposes. The transaction is material to investors as it significantly increases share count and dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses an unregistered sale of 356 Series A Convertible Preferred Shares to TriCore Foundation, LLC for $320,400 on June 17, 2026, made in reliance on Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance under Item 3.02, involving convertible securities sold to a related party without registration. The transaction is material as it represents new equity capital raised and potential dilution to existing shareholders upon conversion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-23
Item 1.01
AMASS Brands invested $1,535,000 (after amendment) in AfterDream via a SAFE agreement, which is a form of convertible equity instrument that will convert into shares upon future triggering events (Equity Financing, Liquidity Event, or Dissolution Event). While the SAFE is technically an investment by AMASS rather than an issuance by AMASS, the structure and mechanics—conversion into equity at a valuation cap with dilutive potential—align with the dilutive_issuance category's focus on equity capital raises. However, this could also be classified as a material investment or financial transaction under financial_other if viewed as AMASS deploying capital rather than raising it. The Item 1.01 designation and the material dollar amount ($1.535M) support materiality.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-23
Item 3.02
The Fund sold 341,423 Class I common shares for $9.2 million during June 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The filing discloses an unregistered sale of equity securities under Item 3.02, specifically the issuance of 179,051 shares of Series A Convertible Preferred Stock in a Rule 506(b) private placement during June 2026, generating $1.735 million in gross proceeds. This is a dilutive equity issuance to accredited investors that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The filing discloses multiple unregistered sales of equity securities (Class E and Class I common shares) totaling approximately $3.15 million in aggregate consideration, issued pursuant to Section 4(a)(2) of the Securities Act. These include management fee payments to the Adviser (107,584 Class I shares), distribution reinvestment plan issuances to Brookfield affiliates (162,691 Class I shares and 23,894 Class E shares), and reinvestment plan issuances to a feeder vehicle for non-U.S. persons (9,344 Class I shares). The issuance of unregistered equity securities, particularly to related parties and in connection with management compensation and reinvestment programs, is material to investors as it dilutes existing shareholders and affects the capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Blackstone Private Credit Fund completed an unregistered sale of 278,469 Class I common shares for $6.67 million, exempt under Section 4(a)(2) and Regulation S, representing a private placement that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-23
Item 1.01
FiEE entered into an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners on June 23, 2026, authorizing the issuance of up to $6.27 million in common stock shares. This is a classic dilutive equity issuance under an ATM program, which allows the company to raise capital by selling shares at market prices. The disclosure explicitly references the shelf registration statement (Form S-3) and prospectus supplement filed in connection with the offering, and the company retains discretion over timing and amount of sales. Such equity offerings are material to investors as they dilute existing shareholders and signal capital needs.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Ares Core Infrastructure Fund sold 34.1 million Common Shares across four classes for an aggregate purchase price of $851.3 million in a private placement exempt from Securities Act registration under Section 4(a)(2) and Regulation D Rule 506(b).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Golub Capital Private Income Fund S issued 71,086 common shares of beneficial interest for approximately $1.72 million in an unregistered sale exempt under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The Fund sold 102,555 unregistered common shares of beneficial interest for $2,489,000 as of June 1, 2026, pursuant to subscription agreements and exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-22
Item 1.01
HIVE amended and restated its Equity Distribution Agreement on June 16, 2026, authorizing the sale of up to US$300 million in common shares through an at-the-market offering, with $214.7 million in unused offering capacity as of the prospectus supplement filed June 17, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Stone Point Credit Income Fund disclosed the unregistered sale of 1,013,220.501 common shares at NAV for $25,000,000 aggregate offering price, plus an additional 495,413.844 shares for $12,223,742, pursuant to subscription agreements with accredited investors under Section 4(a)(2) and Regulation D Rule 506. This is a classic dilutive private placement of equity securities exempt from registration, material to investors assessing the Fund's capital structure and the dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 3.02
Third Point Private Capital Partners completed an unregistered sale of 384,766 Class I common shares for $10,000,000 as of May 1, 2026, relying on Section 4(a)(2) and Regulations D and S exemptions to accredited investors and non-U.S. persons.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-22
Item 3.02
The Company issued 200,000 shares of Class B common stock to CEO/Chairman Huan Liu at $2.00 per share ($400,000 gross proceeds) in an unregistered private placement under Regulation S and Section 4(a)(2). The restricted securities issuance dilutes existing shareholders and represents a material insider transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-22
Item 8.01
Deep Fission completed a public offering of 2.5 million shares at $16.00 per share, generating $40 million in gross proceeds, with an additional 375,000-share greenshoe option granted to underwriters. While this is a registered public offering (not an unregistered private placement), it represents a material dilutive issuance of equity that would significantly affect a reasonable investor's assessment of ownership and capital structure, particularly for a newly public company (trading began June 18, 2026).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-22
Item 8.01
The Company issued 2,727,272 warrants to Maxim Group LLC as part of a settlement arrangement, with the warrants exercisable into common stock at $0.6325 per share. This represents a dilutive equity issuance to a placement agent in connection with the Company's at-the-market offering program. The warrant issuance, combined with the $1,050,000 cash fee and future 3% commission on ATM proceeds, constitutes material consideration for capital-raising services and would materially dilute existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-22
Item 8.01
The Company completed an initial public offering of 5.5 million shares at $12.50 per share, generating approximately $68.75 million in gross proceeds. This material capital-raising event significantly affects the registrant's capitalization and ownership structure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-22
RedHill Biopharma entered into a Securities Purchase Agreement on June 18, 2026, for a private placement of 8,571,429 ADSs (each representing 10,000 ordinary shares), Series A-1 and Series A-2 warrants, and pre-funded warrants at a combined purchase price of $0.70 per ADS and accompanying warrants. The offering is expected to generate approximately $6 million in gross proceeds, with potential additional proceeds of $13.4 million if warrants are fully exercised. This is a classic dilutive equity issuance to an accredited investor under Section 4(a)(2) and Regulation D, materially affecting shareholder ownership and voting rights.
View raw filing on EDGAR →